pathways.medical-psilocybin.org

New Mexico medical psilocybin program · proposed 7.35.3 NMAC

Proposed rule

Patients

Enrollment as a qualified patient. The Act defines the qualified patient and the qualifying conditions; the proposed Part 3 sets the enrollment application, and none of it is in effect.

One of the pathways. Sources read September 8, 2026.

RULE7.35.3 NMAC, proposed and not in effect. The draft published August 25, 2026 is the current text; the definitions of 7.35.2.7 NMAC apply to it, 7.35.3.7, p. 1. The draft, section by section
STATUSProposed. Public hearing Friday, October 2, 2026, 9:00 a.m., Harold Runnels Building auditorium, 1190 St. Francis Drive, Santa Fe, by video and telephone as well, with written comment accepted. Notice of public hearing, August 25, 2026; the record
APPLYNot yet. No application exists until the rule is adopted and takes effect. The draft has the application filed "using the electronic system designated by the department," 7.35.3.8, p. 1.

What the draft asks of a patient

Who files. The application is submitted by the patient and the patient's certifying clinician together, through the department's electronic system. 7.35.3.8, p. 1

What the patient submits. Legal name, address, telephone, and e-mail; date of birth; the certifying clinician's name; a legible copy of a driver's license or comparable photo identification; signature and date; a signed consent for release of medical information related to the qualifying condition; and the further items the section lists. 7.35.3.8 (A), p. 1

The qualifying conditions are the statute's. Section 26-2D-3 NMSA 1978

Once enrolled. Authorized possession, purchase, and sale at 7.35.3.14, p. 9; prohibitions and limitations for patients at 7.35.3.22, p. 16; complaints at 7.35.3.24, p. 16; withdrawal at 7.35.3.26, p. 17.

On the rules site

The statute, section by section; 7.35.3 NMAC and its rulemaking record.